tiprankstipranks
Advertisement
Advertisement

Jin Medical Shareholders Approve Dual-Class Structure and Conditional Reverse Splits

Story Highlights
  • On January 30, 2026, Jin Medical shareholders approved a dual-class share structure, issuing new Class A and high-vote Class B shares while cancelling the old ordinary shares.
  • Investors also adopted new governing documents and authorized conditional reverse share consolidations to support trading price levels and strengthen capital markets flexibility.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Jin Medical Shareholders Approve Dual-Class Structure and Conditional Reverse Splits

Claim 30% Off TipRanks

An update from Jin Medical International Ltd. ( (ZJYL) ) is now available.

At an extraordinary general meeting held on January 30, 2026, Jin Medical International Ltd. shareholders approved a sweeping overhaul of the company’s capital structure, including the creation of a dual-class share system. The authorized capital was reconfigured into 900 million Class A ordinary shares with one vote per share and 100 million Class B ordinary shares with 30 votes per share, accompanied by a pro rata issuance of approximately 136.5 million Class A shares to existing shareholders (excluding Jolly Harmony Enterprises Limited) and 20 million Class B shares to Jolly Harmony, followed by the repurchase and cancellation of the previously issued ordinary shares and a reduction of authorized but unissued ordinary shares to align with the new dual-class structure. Investors also backed the adoption of a second amended and restated memorandum and articles of association to formalize the dual-class regime, and approved a series of conditional, board-discretionary share consolidations to be implemented within two years if the market price of the Class A shares falls below $1.00, measures that collectively are designed to strengthen control for the key shareholder, enhance flexibility in managing listing compliance, and potentially support the company’s positioning in U.S. capital markets.

More about Jin Medical International Ltd.

Jin Medical International Ltd., incorporated in the Cayman Islands and headquartered in Changzhou, Jiangsu Province, China, is listed in the United States as a foreign private issuer and operates through a structure of ordinary shares held by global investors. The company files annual reports on Form 20-F and maintains an effective F-3 shelf registration, positioning it to access U.S. capital markets for future financing activities.

Average Trading Volume: 1,104,884

Technical Sentiment Signal: Sell

Current Market Cap: $20.99M

Find detailed analytics on ZJYL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1